205071 - A phase IV, longitudinal, cross-sectional, retrospective, ancillary epidemiology study of the EPI-MAL-005 study to evaluate the genetic diversity in the Plasmodium falciparum parasite circumsporozoite sequences before and after the implementation of the RTS,S/AS01E vaccine in malaria-positive subjects ranging from 6 months to less than 5 years of age (EPI-MALARIA-010 VS AME)

07/10/2021
17/12/2025
EU PAS number:
EUPAS42948
Study
Finalised
Documents
Study protocol
Initial protocol
English (817.71 KB - PDF) View document
Study results
Study report
Study report
English (3.25 MB - PDF) View document
Other information